Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Difficult to Treat Depression
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
J. Steven Lamberti, MD
PCC
Original Research
GLP-1 Analogs in Patients on Antipsychotics
February 6, 2020
Certain antipsychotics are known to increase weight and the risk for diabetes. Could some medications for diabetes promote not only glycemic control but also weight loss in patients taking...
Lauren T. Perlis
,
J. Steven Lamberti
,
Susanne U. Miedlich
JCP
Original Research
Changes in Metabolic Parameters With Switching to Aripiprazole From Another Second-Generation Antipsychotic: A Retrospective Chart Review
March 15, 2007
Ronald D. Spurling
,
J. Steven Lamberti
,
David Olsen
, et al
JCP
Original Research
Diabetes Mellitus Among Outpatients Receiving Clozapine: Prevalence and Clinical-Demographic Correlates
July 15, 2005
J. Steven Lamberti
,
G. Oana Costea
,
David Olson
, et al
JCP
Original Research
Prevalence of Diabetes Mellitus Among Outpatients With Severe Mental Disorders Receiving Atypical Antipsychotic Drugs
May 1, 2004
J. Steven Lamberti
,
John F. Crilly
,
Kumar Maharaj
, et al
JCP
Letter to the Editor
Priapism Associated With Polypharmacy
February 2, 2001
Anca Seger
,
J. Steven Lamberti
JCP
Letter to the Editor
Is Antipsychotic Drug-Induced Weight Gain Associated With a Favorable Clinical Response?
September 30, 2000
J. Steven Lamberti
